Skip to main content

Bariatric Surgery Candidate clinical trials at University of California Health

3 in progress, 2 open to eligible people

Showing trials for
  • Denosumab to Prevent High-Turnover Bone Loss After Bariatric Surgery

    open to eligible people ages 25 years and up

    Bariatric surgery leads to bone loss and increases fracture risk. This study evaluates whether denosumab can prevent the high-turnover bone loss that occurs after Roux-en-Y Gastric Bypass (RYGB) and sleeve gastrectomy (SG) surgery.

    at UCSF

  • Multimodal Analgesia Effect on Post Surgical Patient

    open to eligible females ages 35-65

    Patients undergoing Bariatric Surgery at the University of California Davis Medical Center will be divided into two groups, one receiving Standard of Care pain control medications vs the second group which will receive non-narcotic pain medications with rescue pain medications available if needed

    at UC Davis

  • Cognitive Impairment, Obesity, and the Effects of Bariatric Surgery

    Sorry, accepting new patients by invitation only

    Study is designed to screen psychological cognitive baseline and retention/improvement after weight loss surgery.

    at UC Davis

Our lead scientists for Bariatric Surgery Candidate research studies include .

Last updated: